The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment of EBV+ nasopharyngeal carcinoma with banked EBV-specific cytotoxic T cells.
 
Susan Prockop
Research Funding - Atara Biotherapeutics (Inst)
 
Ekatarina Doubrovina
Consulting or Advisory Role - Atara Biotherapeutics
Patents, Royalties, Other Intellectual Property - Atara Biotherapeutics
Travel, Accommodations, Expenses - Atara Biotherapeutics
 
Shrujal S. Baxi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca
 
Virginia Escobedo
No Relationships to Disclose
 
Stephanie Suser
Research Funding - Atara Biotherapeutics (Inst)
 
Victoria Szenes
No Relationships to Disclose
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; Exelixis; Genentech; GlaxoSmithKline; Lilly; MedImmune; Merck; Novartis
 
Richard J. O'Reilly
Honoraria - Atara Biotherapeutics
Research Funding - Atara Biotherapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Atara Biotherapeutics (Inst)
Travel, Accommodations, Expenses - Atara Biotherapeutics